Neoadjuvant therapy (NAT) is increasingly being used for pancreatic ductal adenocarcinoma (PDAC). This study investigates how NAT differentially impacts PDAC’s carcinoma cells and the tumor ...
The alternative text for this image may have been generated using AI. In the current study, we have profiled the expression of 48 complement genes in different lung cells through bioinformatics ...
The MarketWatch News Department was not involved in the creation of this content. -- Commit Biologics is pioneering a novel approach to activating the complement component of the immune system to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results